Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

Justin Taylor, Xiaoli Mi, Alexander V. Penson, Stella V. Paffenholz, Kelsey Alvarez, Allison Sigler, Stephen S. Chung, Raajit K. Rampal, Jae H. Park, Eytan M. Stein, Martin S. Tallman, Filiz Sen, Mithat Gönen, Omar Abdel-Wahab, Virginia M. Klimek

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Sort by
Weight
Alphabetically

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

Fingerprint

Medicine & Life Sciences